Home › Trials › NCT03549754

Global registry for patients with type 2 diabetes and related conditions

Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases

Observational AstraZeneca · NCT03549754

This study is collecting information from doctors around the world about patients with type 2 diabetes and related health issues to better understand how these conditions are managed and treated.

Quick facts

Study typeObservational
Enrollment35000 (estimated)
Ages18 Years and up
SexAll
SponsorAstraZeneca Industry-sponsored
Locations55 sites (Fortaleza, Ceará and 54 other locations)
Trial IDNCT03549754 on ClinicalTrials.gov

What this trial studies

This observational registry aims to collect real-world data on patient characteristics, disease management, healthcare utilization, and outcomes for individuals with type 2 diabetes, hypertension, heart failure, and chronic kidney disease. It will utilize a cloud-based electronic case report form (eCRF) for both prospective and retrospective data collection, making it accessible to investigators and a Scientific Committee. The registry is open to physicians worldwide who manage these conditions, facilitating a comprehensive understanding of patient care in clinical practice.

Who should consider this trial

Good fit: Ideal candidates for this registry are adults aged 18 and older diagnosed with type 2 diabetes, hypertension, heart failure, and/or chronic kidney disease.

Not a fit: Patients with life-threatening co-morbidities and a life expectancy of less than one year may not benefit from participation in this registry.

Why it matters

Potential benefit: If successful, this registry could enhance the understanding of disease management and improve healthcare outcomes for patients with these chronic conditions.

How similar studies have performed: Other observational registries have successfully provided valuable insights into chronic disease management, indicating that this approach is both tested and beneficial.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. Being 18 years or older
2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
3. Providing written informed consent to participate in the registry

Exclusion Criteria:

1. Having a life-threatening co-morbidity with life expectancy below 1 year
2. Participating in an interventional trial requiring informed consent

Where this trial is running

Fortaleza, Ceará and 54 other locations

+5 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Type 2 DiabetesHypertensionChronic Kidney DiseaseHeart FailureRegistryT2DMCKDHTN
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.